HOME >> MEDICINE >> NEWS
First mouse model for multiple system atrophy points to new treatment targets for brain diseases

(Philadelphia, PA) A newly developed animal model for Multiple System Atrophy (MSA) a collection of neurodegenerative disorders once thought to be three separate diseases sheds new light on this little-studied brain disease, according to research from investigators at the University of Pennsylvania School of Medicine.

Virginia M.-Y. Lee, PhD, Director of Penn's Center for Neurodegenerative Disease Research, and colleagues demonstrated that the mice showed symptoms similar to human MSA. These include an accumulation of a protein called -synuclein in oligodendrocytes cells that produce the protective myelin sheath that covers axons. This protein accumulation disables oligodendrocytes, leading to a loss of the sheath on neurons and eventually nerve-cell malfunction and death. The mice also showed slowly progressive problems with their motor skills associated with the nerve-cell damage. Neurons are important in transmitting signals and in maintaining learning and memory.

"The uniqueness of this disease is that, unlike most of the neurodegenerative diseases, which affect neurons primarily and oligodendrocytes secondarily, this is the other way around," says Lee. In fact, there is growing evidence that non-neuronal cells also play a role in amyloid deposits in Alzheimer's disease and amyotrophic lateral sclerosis (ALS) mouse models. Lee and colleagues report their findings in the March 24, 2005 issue of Neuron.

MSA is so named because it affects multiple parts of the nervous system. Initially MSA was given three names, based on the symptoms physicians had observed. However, when they closely examined patients' pathology, the disorders seemed related, based on the -synuclein proteins in cells. In the clinic, many patients with MSA present with symptoms similar to Parkinson's disease (PD), and MSA has been misdiagnosed as such.

Collectively, MSA now includes three related disorders characterized by their most prominent symptoms: olivopo
'"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-662-2560
University of Pennsylvania School of Medicine
23-Mar-2005


Page: 1 2

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. First UK cases of previously rare disease reported in gay men
3. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
4. First US kidney cancer vaccine trial underway at Columbia
5. First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)
6. First blood test to diagnose paralyzing, blinding disease
7. First US SARS vaccine trial opens at NIH
8. First-ever safety study of medical cannabis use in Canada launched
9. First solid evidence that the study of music promotes intellectual development
10. First medical test on CD gets good results
11. First proof that cutting Rx drugs due to cost harms health

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2020)... ... February 28, 2020 , ... ... Morning Recovery, launches a new product, Liquid Focus , this week. Their ... mind, provide steady energy, and ease stress. , As a healthier alternative ...
(Date:2/28/2020)... ... February 28, 2020 , ... ... authorized e-filer to the state of New Jersey in connection with new legislation ... requires that every New Jersey resident must either obtain health insurance, have a ...
(Date:2/26/2020)... ... February 26, 2020 , ... Join the live webinar ... Ionescu-Zanetti, PhD, Chief Technology Officer, Fluxion Biosciences as he provides an overview of ... for high-sensitivity circulating tumor cell (CTC) enrichment and recovery from blood samples, including ...
(Date:2/23/2020)... ... February 22, 2020 , ... Although many people ... Queendom.com reveals that some people who dismiss compliments struggle with their ... from 9,568 who took the Emotional Intelligence Test, Queendom researchers focused ...
(Date:2/21/2020)... ... February 21, 2020 , ... Used for ... continues to garner traction as a viable replacement for invasive cosmetic surgery, such ... is predicted to remain the market leader for the expected robust growth of ...
Breaking Medicine News(10 mins):
(Date:2/20/2020)... ... ... Enquire, a leading provider of cloud CRM, marketing automation and sales contact ... a Silver Sponsor of Enquire Summit 2020, scheduled for April 20 - 22, 2020 ... a Silver Sponsor. This event truly empowers sales and marketing professionals in the senior ...
(Date:2/19/2020)... N.C. (PRWEB) , ... February 19, 2020 , ... A ... the presence of oxygen-deprived clusters throughout the damaged site of a compressed spinal cord. ... use of a viral vector to target the oxygen-deprived sites enhances the injured spinal ...
(Date:2/19/2020)... ... February 19, 2020 , ... ... platforms. Molecular diagnostics platforms are increasingly becoming popular as they enable accurate diagnosis ... the market for molecular cancer diagnostics, including histology and assays, reached $1.6 billion, ...
Breaking Medicine Technology:
Cached News: